References
- Garratty G. The role of compatibility tests. Transfusion 1982;22:169–72.
- Office of Biologics Research and Review, National Center for Drugs and Biologics, United States. Equivalent methods for compatibility testing: memorandum to blood establishments. Washington, DC: Food and Drug Administration, 1984.
- AABB. Standards for blood banks and transfusion services, 31st ed. Bethesda, MD: AABB, 2018.
- Chow EY. The impact of the type and screen test policy on hospital transfusion practice. Hong Kong Med J 1999;5:275–9.
- Cordle DG, Strauss RG, Snyder EL, Floss AM. Safety and cost-containment data that advocate abbreviated pretransfusion testing. Am J Clin Pathol 1990;94:428–31.
- Heddle NM, O’Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992;81:579–84.
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB Press, 2017.
- Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137–41.
- Marosszeky S, McDonald S, Sutherland J, et al. Suitability of preadmission blood samples for pretransfusion testing in elective surgery. Transfusion 1997;37:910–2.
- Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42–5.
- Chow EY. The impact of the type and screen test policy on hospital transfusion practice. Hong Kong Med J 1999;5:275–9.
- Zeerleder S. Autoimmune haemolytic anaemia: a practical guide to cope with a diagnostic and therapeutic challenge. Neth J Med 2011;69:177–84.
- Uthemann H, Poschmann A. Solid-phase antiglobulin test for screening and identification of red cell antibodies. Transfusion 1990;30:114–6.
- Agrawal A. Type and screen policy: is there any compromise on blood safety? Transfus Apher Sci 2014;50:271–3.
- Pathak S, Chandrashekhar M, Wankhede GR. Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India. Asian J Transfus Sci 2011;5:153–6.
- Chaudhary R, Agarwal N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci 2011;5:157.
- Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen–negative recipients. Asian J Transfus Sci 2017;11:40–4.
- Milkins C, Berryma J, Cantwell C, et al. Guidelines for pretransfusion compatibility procedures in blood transfusion laboratories. Transfus Med 2013;23:3–35.
- Aggarwal G, Tiwari AK, Arora D, et al. Advantages of type and screen policy: perspective from a developing country! Asian J Transfus Sci 2018;12:42–5.
- Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012;52:2220–4.
- Moise KJ Jr. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;92:75–81.
- Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.
- Tiwari AK, Pandey P, Sharma J, Shailja K, Dixit S, Raina V. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India. Transfus Apher Sci 2014;50:230–4.
- Pahuja S, Gupta SK, Pujani M, Jain M. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus 2011;9:388.
- LaSalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.
- Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.
- Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.
- Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201.
- Gogri H, Kulkarni S, Vasantha K, Jadhav S, Ghosh K, Gorakshakar A. Partial matching of blood group antigens to reduce alloimmunization in Western India. Transfus Apher Sci 2016;54:390–5.
- Pal M, Williams B. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pathology 2015;47:151–5.
- Elhence P, Solanki A, Verma A. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review. Indian J Hematol Blood Transfus 2014;30:301–8.
- Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh ZR. RBC alloimmunization in blood transfusion-dependent β-thalassemia patients in southern Iran. Int J Lab Hematol 2007;29:321–6.
- Agrawal A, Mathur A, Dontula S, Jagannathan L. Red blood cell alloimmunization in multi-transfused patients: a bicentric study in India. Glob J Transfus Med 2016;1:12.
- Zaman S, Chaurasia R, Chatterjee K, Thapliyal RM. Prevalence and specificity of RBC alloantibodies in Indian patients attending a tertiary care hospital. Adv Hematol 2014; 2014:749218.
- Ho HK, Ha SY, Lam CK, et al. Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. Blood 2001;97:3999–4000.
- Bhagwat SN, Sharma JH, Jose J, Modi CJ. Comparison between conventional and automated techniques for blood grouping and crossmatching: experience from a tertiary care centre. J Lab Physicians 2015;7:96.
- Nathalang O, Chuansumrit A, Prayoonwiwat W, Siripoonya P, Sriphaisal T. Comparison between the conventional tube technique and the gel technique in direct antiglobulin tests. Vox Sang 1997;72:169–71.
- Das SS, Chaudhary R, Khetan D. A comparison of conventional tube test and gel technique in evaluation of direct antiglobulin test. Hematology 2007;12:175–8.
- Novaretti MC, Jens E, Pagliarini T, Bonifacio SL, Dorlhiac–Llacer PE, Chamone DA. Comparison of conventional tube test technique and gel microcolumn assay for direct antiglobulin test: a large study. J Clin Lab Anal 2004;18:255–8.
- Weisbach V, Kohnhäuser T, Zimmermann R, et al. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med 2006;16:276–84.
- Bajpai M, Kaur R, Gupta E. Automation in immunohematology. Asian J Transfus Sci 2012;6:140.